Jieyi Ma

1.9k total citations
37 papers, 1.3k citations indexed

About

Jieyi Ma is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Jieyi Ma has authored 37 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 17 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Jieyi Ma's work include RNA modifications and cancer (15 papers), Cancer-related molecular mechanisms research (11 papers) and Cancer-related gene regulation (10 papers). Jieyi Ma is often cited by papers focused on RNA modifications and cancer (15 papers), Cancer-related molecular mechanisms research (11 papers) and Cancer-related gene regulation (10 papers). Jieyi Ma collaborates with scholars based in China, South Korea and United States. Jieyi Ma's co-authors include Hui Han, Chunlong Yang, Wenjian Wang, Shuibin Lin, Jiong Bi, Siyi Zheng, Shenming Wang, Guangqi Chang, Lu Wang and Siyao Guo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Jieyi Ma

36 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jieyi Ma China 20 1.1k 656 171 117 71 37 1.3k
Wendi Hu China 14 835 0.8× 577 0.9× 141 0.8× 143 1.2× 48 0.7× 23 1.0k
Sida Qin China 21 826 0.8× 575 0.9× 287 1.7× 87 0.7× 65 0.9× 47 1.1k
Lu Zang China 12 716 0.7× 448 0.7× 216 1.3× 111 0.9× 81 1.1× 26 923
Yongqian Shu China 16 658 0.6× 347 0.5× 135 0.8× 88 0.8× 43 0.6× 22 773
Changye Zou China 18 901 0.8× 523 0.8× 189 1.1× 164 1.4× 71 1.0× 31 1.2k
Liang Shi China 22 906 0.8× 569 0.9× 108 0.6× 91 0.8× 37 0.5× 37 1.1k
Yingke Liang China 13 763 0.7× 551 0.8× 253 1.5× 158 1.4× 124 1.7× 29 1.1k
Qi-Nian Wu China 13 1.6k 1.4× 1.2k 1.8× 262 1.5× 145 1.2× 142 2.0× 14 1.9k
Zhirui Zeng China 17 632 0.6× 469 0.7× 138 0.8× 164 1.4× 105 1.5× 73 887

Countries citing papers authored by Jieyi Ma

Since Specialization
Citations

This map shows the geographic impact of Jieyi Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jieyi Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jieyi Ma more than expected).

Fields of papers citing papers by Jieyi Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jieyi Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jieyi Ma. The network helps show where Jieyi Ma may publish in the future.

Co-authorship network of co-authors of Jieyi Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Jieyi Ma. A scholar is included among the top collaborators of Jieyi Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jieyi Ma. Jieyi Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Siyao, Qiang Zhang, Jieyi Ma, et al.. (2025). PABPN1-C5 axis promotes hepatocellular carcinoma progression via NF-κB activation. Oncogene. 44(37). 3512–3524.
2.
Jiang, Yaling, et al.. (2024). Modified banana peel biochar-based green nanocatalyst for biodiesel production and its utilization to improve diesel engine performance and emission. Process Safety and Environmental Protection. 191. 1617–1632. 9 indexed citations
3.
Jiang, Yaling, et al.. (2024). Evaluation of the perturbed hard-sphere-chain equation of state for calculations of methane hydrate formation condition in the presence of ionic liquids. International Journal of Hydrogen Energy. 68. 1331–1343. 1 indexed citations
4.
Han, Hui, Wei Wei, Zixin Huang, et al.. (2024). RNA modification-related genes illuminate prognostic signature and mechanism in esophageal squamous cell carcinoma. iScience. 27(3). 109327–109327. 6 indexed citations
5.
Lei, Kexin, Hui Han, Yaqian Chen, et al.. (2024). Metabolic rewiring during bone development underlies tRNA m7G–associated primordial dwarfism. Journal of Clinical Investigation. 134(20). 7 indexed citations
6.
Li, Kang, Caihua Zhang, Maosheng Cheng, et al.. (2024). Single cell analysis unveils B cell-dominated immune subtypes in HNSCC for enhanced prognostic and therapeutic stratification. International Journal of Oral Science. 16(1). 29–29. 11 indexed citations
7.
Ma, Jieyi, Siyi Zheng, Chenrui An, et al.. (2024). Pathogenic mechanism and therapeutic intervention of impaired N 7 -methylguanosine (m 7 G) tRNA modification. Proceedings of the National Academy of Sciences. 121(45). e2405886121–e2405886121. 6 indexed citations
8.
Wang, Zhaoyu, Peng Yu, Yutong Zou, et al.. (2023). METTL1/WDR4-mediated tRNA m7G modification and mRNA translation control promote oncogenesis and doxorubicin resistance. Oncogene. 42(23). 1900–1912. 33 indexed citations
9.
Li, Kang, Jie Chen, Caihua Zhang, et al.. (2023). The CTBP2-PCIF1 complex regulates m6Am modification of mRNA in head and neck squamous cell carcinoma. Journal of Clinical Investigation. 133(20). 18 indexed citations
10.
Han, Hui, Chunlong Yang, Jieyi Ma, et al.. (2022). N7-methylguanosine tRNA modification promotes esophageal squamous cell carcinoma tumorigenesis via the RPTOR/ULK1/autophagy axis. Nature Communications. 13(1). 1478–1478. 125 indexed citations
11.
Peng, Hao, Binbin Chen, Wei Wei, et al.. (2022). N6-methyladenosine (m6A) in 18S rRNA promotes fatty acid metabolism and oncogenic transformation. Nature Metabolism. 4(8). 1041–1054. 95 indexed citations
12.
Huang, Ying, Jieyi Ma, Hui Han, et al.. (2022). METTL1 promotes neuroblastoma development through m7G tRNA modification and selective oncogenic gene translation. Biomarker Research. 10(1). 68–68. 21 indexed citations
13.
Liang, Yu, Hui Han, Qiuchan Xiong, et al.. (2021). METTL3-Mediated m6A Methylation Regulates Muscle Stem Cells and Muscle Regeneration by Notch Signaling Pathway. Stem Cells International. 2021. 1–13. 45 indexed citations
14.
Xu, Yanyan, Tao Yao, Kangmao Huang, et al.. (2020). Circular RNA circTUBGCP3 Is Up-Regulated and Promotes Cell Proliferation, Migration and Survivability via Sponge mir-30b in Osteosarcoma. SHILAP Revista de lepidopterología. 2 indexed citations
15.
Li, Lei, Xu Chen, Qiao Su, et al.. (2020). DAPK3 inhibits gastric cancer progression via activation of ULK1-dependent autophagy. Cell Death and Differentiation. 28(3). 952–967. 55 indexed citations
16.
Chen, Fan, Jiong Bi, Wen Li, et al.. (2018). Evaluation of the prognostic value of paraoxonase 1 in the recurrence and metastasis of hepatocellular carcinoma and establishment of a liver-specific predictive model of survival. Journal of Translational Medicine. 16(1). 327–327. 20 indexed citations
17.
Li, Wen, Rui Wang, Jieyi Ma, et al.. (2017). A Human Long Non-Coding RNA ALT1 Controls the Cell Cycle of Vascular Endothelial Cells Via ACE2 and Cyclin D1 Pathway. Cellular Physiology and Biochemistry. 43(3). 1152–1167. 15 indexed citations
18.
19.
Chen, Zhibo, Mian Wang, Qiong He, et al.. (2017). MicroRNA-98 rescues proliferation and alleviates ox-LDL-induced apoptosis in HUVECs by targeting LOX-1. Experimental and Therapeutic Medicine. 13(5). 1702–1710. 40 indexed citations
20.
Zhu, Xiao‐Feng, et al.. (2017). HMOX-1 inhibits TGF-β-induced epithelial-mesenchymal transition in the MCF-7 breast cancer cell line. International Journal of Molecular Medicine. 40(2). 411–417. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wendi Hu Breakdown of academic impact, for papers by Sida Qin Breakdown of academic impact, for papers by Lu Zang Breakdown of academic impact, for papers by Yongqian Shu Breakdown of academic impact, for papers by Changye Zou Breakdown of academic impact, for papers by Liang Shi Breakdown of academic impact, for papers by Yingke Liang Breakdown of academic impact, for papers by Qi-Nian Wu Breakdown of academic impact, for papers by Zhirui Zeng
Rankless by CCL
2026